Literature DB >> 6340491

The changing clinical spectrum of primary aldosteronism.

E L Bravo, R C Tarazi, H P Dustan, F M Fouad, S C Textor, R W Gifford, D G Vidt.   

Abstract

In a prospective study of 80 patients with primary aldosteronism (70 with adenoma and 10 with hyperplasia), "refractory" hypertension, hyperkinetic circulation, and hypovolemia were frequent occurrences. We found that measurements of serum potassium concentration and plasma renin activity were inadequate screening tests because of high rates of false-positive and false-negative results. The demonstration of excessive aldosterone production after three days of salt loading provided the best sensitivity (96 percent) and specificity (93 percent) in identifying patients with primary aldosteronism. Severe, persistent hypokalemia, increased plasma 18-hydroxycorticosterone values, and an anomalous postural decrease in the plasma aldosterone concentration, when present, provided the best indicators of the presence of an adenoma. Of three localizing procedures (selective adrenal venography, adrenal computed tomographic scan, and adrenal venous sampling for plasma aldosterone concentration) the measurement of adrenal venous plasma aldosterone concentration yielded 100 percent accuracy. These results indicate a wider clinical spectrum in primary aldosteronism than previously described. They also show that nonsuppressible aldosterone production is its most important diagnostic hallmark and the single best diagnostic screening procedure, and that adrenal venous sampling for plasma aldosterone concentration remains the most precise technique for identification and localization of tumors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6340491     DOI: 10.1016/0002-9343(83)91022-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  28 in total

Review 1.  Medical management of primary hyperaldosteronism.

Authors:  E L Bravo
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

2.  A case of primary aldosteronism with end stage renal disease.

Authors:  Hyun Hee Na; Kyung Jun Park; Sun Young Kim; Haeng Il Koh
Journal:  Electrolyte Blood Press       Date:  2006-11

Review 3.  Primary aldosteronism and a Texas two-step.

Authors:  Richard J Auchus
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

4.  Primary aldosteronism associated with a germline variant in CACNA1H.

Authors:  Kendra Wulczyn; Edward Perez-Reyes; Robert L Nussbaum; Meyeon Park
Journal:  BMJ Case Rep       Date:  2019-05-23

5.  Cosyntropin stimulation in adrenal vein testing for aldosteronoma.

Authors:  R H Noth; S L Glaser; J C Palmaz
Journal:  West J Med       Date:  1985-01

Review 6.  Low-renin hypertension of childhood.

Authors:  J DiMartino-Nardi; M I New
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

7.  Screening for primary aldosteronism: hypokalemia in hypertensive patients.

Authors:  K Goldenberg; D K Snyder
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

8.  Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension.

Authors:  G T Griffing; B Berelowitz; M Hudson; R Salzman; J A Manson; S Aurrechia; J C Melby; R C Pedersen; A C Brownie
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glands.

Authors:  T Jeck; B Weisser; T Mengden; L Erdmenger; S Grüne; W Vetter
Journal:  Clin Investig       Date:  1994-12

10.  Aldosterone excess: a rare non-nephrophathic cause of hypertension in type I diabetes.

Authors:  N N Chan; M D Feher
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.